SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Future of Nanomedicine: Obstacles and Remedies
10 references·0 citing·40 second hop
Future of Nanomedicine: Obstacles and Remedies (2011)Future of Nanomedicine: Obstacles and Rem…The Neural Basis of Loss Aversion in Decision-Making Under Risk (2007)The Neural Basis of Loss Aver…Patents and Nanomedicine (2007)Patents and NanomedicineBridging the gap between foresight and market research: Integrating methods to assess the economic potential of nanotechnology (2007)Bridging the gap between fore…Protecting new ideas and inventions in nanomedicine with patents (2005)Protecting new ideas and inve…Bioequivalence and other unresolved issues in generic drug substitution (2003)Bioequivalence and other unre…Timid Choices and Bold Forecasts: A Cognitive Perspective on Risk Taking (2000)Timid Choices and Bold Foreca…Longer Patents for Increased Generic Competition in the US (1996)Longer Patents for Increased …Timid Choices and Bold Forecasts: A Cognitive Perspective on Risk Taking (1993)Timid Choices and Bold Foreca…Liability for Harm versus Regulation of Safety (1984)Liability for Harm versus Reg…Liability for Harm Versus Regulation of Safety (1983)Liability for Harm Versus Reg…Judgment under Uncertainty: Heuristics and Biases (1975)Prospect theory: An analysis of decision under risk (1988)Advances in prospect theory: Cumulative representation of uncertainty (1992)The myopia of learning (1993)A perspective on judgment and choice: Mapping bounded rationality. (2003)Explicating dynamic capabilities: the nature and microfoundations of (sustainable) enterprise performance (2007)Cost of innovation in the pharmaceutical industry (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Against Intellectual Monopoly (2008)Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States (2016)Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry (2016)Political science research methods (1986)New Product Development in Rapidly Changing Markets: An Exploratory Study (1998)The over-optimism among experts in assessment and foresight (2004)RETRACTED: Technology commercialization intelligence: Organizational antecedents and performance consequences (2008)Which model of technology transfer for nanotechnology? A comparison with biotech and microelectronics (2011)The links between French school of foresight and organizational learning: An assessment of developments in the last ten years (2018)Prospect Theory: An Analysis of Decision under Risk (1979)Social neuroeconomics: the neural circuitry of social preferences (2007)Risky business: the neuroeconomics of decision making under uncertainty (2008)Influencing behaviour: The mindspace way (2011)Longitudinal Patent Analysis for Nanoscale Science and Engineering: Country, Institution and Technology Field (2003)Patents in the Knowledge-Based Economy (2003)A patent system for the 21st Century (2005)Will the nanomedicine “patent land grab” thwart commercialization? (2005)China–US scientific collaboration in nanotechnology: patterns and dynamics (2011)Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting (2000)The price of innovation: new estimates of drug development costs (2003)Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)A collective and abridged lexical query for delineation of nanotechnology publications (2010)Nano-enabled drug delivery: A research profile (2014)A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century (2024)Are there potential problems with generic substitution of antiepileptic drugs? (2006)Patients’ attitudes towards and experiences of generic drug substitution in Norway (2006)An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland (2010)On the joint use of liability and safety regulation (2000)Management-Based Regulation: Prescribing Private Management to Achieve Public Goals (2003)Large Risks, Limited Liability, and Dynamic Moral Hazard (2010)Monitoring vis-a-vis Investigation in Enforcement of Law (1992)The Promise of Enterpreneurship as a Field of Research (2000)
this work references cited by second hop

References

  • 1993Timid Choices and Bold Forecasts: A Cognitive Perspective on Risk Taking2,041 cited
  • 2007The Neural Basis of Loss Aversion in Decision-Making Under Risk1,733 cited
  • 2000Timid Choices and Bold Forecasts: A Cognitive Perspective on Risk Taking1,277 cited
  • 1984Liability for Harm versus Regulation of Safety381 cited
  • 1983Liability for Harm Versus Regulation of Safety285 cited
  • 2003Bioequivalence and other unresolved issues in generic drug substitution213 cited
  • 1996Longer Patents for Increased Generic Competition in the US136 cited
  • 2005Protecting new ideas and inventions in nanomedicine with patents118 cited
  • 2007Patents and Nanomedicine106 cited
  • 2007Bridging the gap between foresight and market research: Integrating methods to assess the economic potential of nanotechnology59 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work